Axordia Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Axordia General Information

Description

Operator of a human embryonic stem cell company. The company develops drugs using the properties of stem cells and their derivatives as part of the drug discovery process.

Contact Information

Website
www.axordia.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • The Sheffield Bioincubator
  • 40 Leavygreave Road
  • Sheffield S3 7RD
  • England, United Kingdom
+44 0114 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axordia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 00.000 Completed Product Development
3. Early Stage VC 01-Jan-2006 00000 00.000 Completed Startup
2. Grant 01-Apr-2002 $362K Completed
1. Early Stage VC 12-Nov-2001 $362K $362K Completed Product Development
To view Axordia’s complete valuation and funding history, request access »

Axordia Patents

  • 24

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Axordia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080213387-A1 Isolated cytotrophoblast stem cell expresses hla-g and hla class i antigen; cytokeratin 7; stage specific embryonic antigen 1; human placental lactogen; caudal related homeobox; vimentin; cd9 marker; chimeric cell for the modulation of cell/tissue rejection in transplantation therapy Abandoned 16-Apr-2005 0000000000 0
CA-2648506-A1 Cytotrophoblast stem cell Abandoned 16-Apr-2005 0000000000
AU-2006238733-A1 Cytotrophoblast stem cell Abandoned 16-Apr-2005 0000000000
GB-0606875-D0 Cytotrophoblast stem cells Granted 16-Apr-2005 0000000000
GB-2425129-A Cytotrophoblast stem cells Granted 16-Apr-2005 C12N5/0606
To view Axordia’s complete patent history, request access »

Axordia Executive Team (1)

Name Title Board Seat Contact Info
V Gerskowitch Chief Executive Officer
To view Axordia’s complete executive team members history, request access »

Axordia Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FusionIP Venture Capital Minority 000 0000 000000 0
White Rose Technology Seedcorn Fund Venture Capital Minority 000 0000 000000 0
To view Axordia’s complete investors history, request access »

Ready to get started?

Request a free trial